{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:49:56Z","timestamp":1770752996307,"version":"3.50.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Postgraduate Research Innovation and Practice Project of Xizang Minzu University","award":["Y2024006"],"award-info":[{"award-number":["Y2024006"]}]},{"name":"A comparative study of the active ingredients of Rhodiola rosea in Tibetan medicine, salidroside and kaempferol, against myocardial injury caused by cytokine storm","award":["24MDY21"],"award-info":[{"award-number":["24MDY21"]}]},{"name":"Mechanism study of the role of Fritillariae Cirrhosae Bulbus component peimisine in inflammatory response","award":["23MDQ02"],"award-info":[{"award-number":["23MDQ02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial ischemia-reperfusion injury (MIRI) markedly impairs cardiac functional recovery and represents a major determinant of adverse outcomes in patients with ischemic heart disease. Ginsenosides, the principal bioactive constituents of ginseng, exert significant cardioprotection against MIRI. This review systematically summarizes and analyzes in vivo (animal) studies to clarify the efficacy and underlying mechanisms of ginsenosides in MIRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The PubMed, EMbase, Web of Science, Cochrane Library, CNKI, WanFang, and Cqvip databases were systematically searched from inception to 31 July 2024. In vivo studies evaluating ginsenosides pretreatment or post-treatment in models of MIRI were identified. Outcome measures comprised myocardial infarct size and indices of hemodynamic performance, myocardial injury, apoptosis, inflammation, and oxidative stress. A meta-analysis was conducted with RevMan 5.4 and Stata\/MP 14.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-four eligible articles encompassing 505 experimental animals were included. Funnel plots, Egger\u2019s tests, and sensitivity analyses confirmed the robustness of the findings. Compared with controls, ginsenosides treatment significantly reduced myocardial infarct size and improved hemodynamic indices (P &lt; 0.0001). Ginsenosides also attenuated MIRI-induced elevations of lactate dehydrogenase, creatine kinase-MB, creatine kinase, malondialdehyde, tumor necrosis factor-\u03b1, interleukin-6, interleukin-1\u03b2, and cardiomyocyte apoptosis (P &lt; 0.0001). Subgroup analysis further revealed that pre-ischemic ginsenosides administration conferred greater protection than post-reperfusion treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ginsenosides play a significant role in the prevention and treatment of MIRI. Ginsenosides can reduce the area of myocardial infarction and improve myocardial damage through anti-inflammatory, antioxidative stress, anti-apoptosis, regulation of autophagy, and energy metabolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05503-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:10:46Z","timestamp":1768396246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preventive and therapeutic effects of ginsenosides on myocardial ischemia-reperfusion injury in animal models: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Hongyi","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"4","key":"5503_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","volume":"4","author":"S Liu","year":"2019","unstructured":"Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, Liu Y, Liu J, Qi J, Ran S, et al. Burden of cardiovascular diseases in China, 1990\u20132016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342\u201352.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"5503_CR2","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1007\/s12350-022-03004-6","volume":"29","author":"M Salarian","year":"2022","unstructured":"Salarian M. The promise of hypericin: a tracer for acute myocardial infarction. J Nucl Cardiol. 2022;29(6):3440\u20132.","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"5503_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12265-019-9863-z","volume":"12","author":"J Curran","year":"2019","unstructured":"Curran J, Burkhoff D, Kloner RA. Beyond reperfusion: acute ventricular unloading and cardioprotection during myocardial infarction. J Cardiovasc Transl Res. 2019;12(2):95\u2013106.","journal-title":"J Cardiovasc Transl Res"},{"issue":"6","key":"5503_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33(6):357\u201366.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"5503_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12906-024-04471-9","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen J, Wang Z, Fu J, Cai Y, Cheng H, Cui X, Sun M, Liu M, Zhang X. Ginsenoside compound K induces ferroptosis via the FOXO pathway in liver cancer cells. BMC Complement Med Ther. 2024;24(1):174.","journal-title":"BMC Complement Med Ther"},{"key":"5503_CR6","doi-asserted-by":"crossref","unstructured":"Liu Z, Cecarini V, Cuccioloni M, Bonfili L, Gong C, Angeletti M, Eleuteri AM. Ginsenosides Rg1 and Rg2 activate autophagy and attenuate oxidative stress in neuroblastoma cells overexpressing A\u03b2(1\u201342). Antioxid (Basel). 2024;13(3):310.","DOI":"10.3390\/antiox13030310"},{"issue":"6","key":"5503_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jgr.2021.12.007","volume":"46","author":"L You","year":"2022","unstructured":"You L, Cha S, Kim MY, Cho JY. Ginsenosides are active ingredients in Panax ginseng with Immunomodulatory properties from cellular to organismal levels. J Ginseng Res. 2022;46(6):711\u201321.","journal-title":"J Ginseng Res"},{"issue":"5","key":"5503_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jvs.2005.01.054","volume":"41","author":"W Zhou","year":"2005","unstructured":"Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in Porcine coronary arteries. J Vasc Surg. 2005;41(5):861\u20138.","journal-title":"J Vasc Surg"},{"issue":"3","key":"5503_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/FJC.0b013e3180cab12e","volume":"50","author":"F He","year":"2007","unstructured":"He F, Guo R, Wu SL, Sun M, Li M. Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. J Cardiovasc Pharmacol. 2007;50(3):314\u201320.","journal-title":"J Cardiovasc Pharmacol"},{"key":"5503_CR10","doi-asserted-by":"publisher","first-page":"1164547","DOI":"10.3389\/fcvm.2023.1164547","volume":"10","author":"W Lu","year":"2023","unstructured":"Lu W, Lin Y, Haider N, Moly P, Wang L, Zhou W. Ginsenoside Rb1 protects human vascular smooth muscle cells against resistin-induced oxidative stress and dysfunction. Front Cardiovasc Med. 2023;10:1164547.","journal-title":"Front Cardiovasc Med"},{"key":"5503_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"10","key":"5503_CR12","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"key":"5503_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2407-14-15","volume":"14","author":"J Chen","year":"2014","unstructured":"Chen J, Zhou J, Lu J, Xiong H, Shi X, Gong L. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis. BMC Cancer. 2014;14:15.","journal-title":"BMC Cancer"},{"key":"5503_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"5503_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"5503_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"5503_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"5503_CR18","doi-asserted-by":"publisher","first-page":"1111459","DOI":"10.3389\/fphar.2023.1111459","volume":"14","author":"T Li","year":"2023","unstructured":"Li T, Jin J, Pu F, Bai Y, Chen Y, Li Y, Wang X. Cardioprotective effects of Curcumin against myocardial I\/R injury: A systematic review and meta-analysis of preclinical and clinical studies. Front Pharmacol. 2023;14:1111459.","journal-title":"Front Pharmacol"},{"issue":"7109","key":"5503_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"5503_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"7414","key":"5503_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"5503_CR22","doi-asserted-by":"publisher","first-page":"6313625","DOI":"10.1155\/2017\/6313625","volume":"2017","author":"Q Zheng","year":"2017","unstructured":"Zheng Q, Bao XY, Zhu PC, Tong Q, Zheng GQ, Wang Y. Ginsenoside Rb1 for myocardial Ischemia\/Reperfusion injury: preclinical evidence and possible mechanisms. Oxid Med Cell Longev. 2017;2017:6313625.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"5503_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jgr.2014.12.001","volume":"39","author":"A Aravinthan","year":"2015","unstructured":"Aravinthan A, Kim JH, Antonisamy P, Kang CW, Choi J, Kim NS, Kim JH. Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties. J Ginseng Res. 2015;39(3):206\u201312.","journal-title":"J Ginseng Res"},{"issue":"06","key":"5503_CR24","first-page":"465","volume":"26","author":"HX Chen","year":"2012","unstructured":"Chen HX. Protective effect of ginsenoside Rb1 on myocardial Ischemia-Reperfusion injury in rats. J Hubei Univ Sci Technol (Medical Sciences). 2012;26(06):465\u20137.","journal-title":"J Hubei Univ Sci Technol (Medical Sciences)"},{"key":"5503_CR25","doi-asserted-by":"publisher","first-page":"44579","DOI":"10.1038\/srep44579","volume":"7","author":"YC Cui","year":"2017","unstructured":"Cui YC, Pan CS, Yan L, Li L, Hu BH, Chang X, Liu YY, Fan JY, Sun K, Li Q, et al. Ginsenoside Rb1 protects against ischemia\/reperfusion-induced myocardial injury via energy metabolism regulation mediated by RhoA signaling pathway. Sci Rep. 2017;7:44579.","journal-title":"Sci Rep"},{"issue":"09","key":"5503_CR26","first-page":"1541","volume":"30","author":"ZX Fan","year":"2021","unstructured":"Fan ZX, Zhang W, Tang YH, Wang X, Li YH, Huang CX. Effects of ginsenoside Rh2 on the levels of NLRP3, IL-1\u03b2, TNF-\u03b1 and SOD activity in rats with myocardial Ischemia-reperfusion injury. J Emerg Traditional Chin Med. 2021;30(09):1541\u20134.","journal-title":"J Emerg Traditional Chin Med"},{"issue":"1","key":"5503_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/etm.2022.11734","volume":"25","author":"ZX Fan","year":"2023","unstructured":"Fan ZX, Yang CJ, Li YH, Yang J, Huang CX. Ginsenoside Rh2 attenuates myocardial ischaemia-reperfusion injury by regulating the Nrf2\/HO-1\/NLRP3 signalling pathway. Exp Ther Med. 2023;25(1):35.","journal-title":"Exp Ther Med"},{"issue":"04","key":"5503_CR28","first-page":"16","volume":"31","author":"X He","year":"2015","unstructured":"He X, Zhang YJ. Ginsenoside Rg1 attenuates myocardial ischemia reperfusion injury through NF-\u03baB signaling pathway. Pharmacol Clin Chin Materia Med. 2015;31(04):16\u20139.","journal-title":"Pharmacol Clin Chin Materia Med"},{"issue":"4","key":"5503_CR29","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.7150\/thno.43895","volume":"11","author":"L Jiang","year":"2021","unstructured":"Jiang L, Yin X, Chen YH, Chen Y, Jiang W, Zheng H, Huang FQ, Liu B, Zhou W, Qi LW, et al. Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia\/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics. 2021;11(4):1703\u201320.","journal-title":"Theranostics"},{"key":"5503_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2019.11.032","volume":"317","author":"L Li","year":"2020","unstructured":"Li L, Wang Y, Guo R, Li S, Ni J, Gao S, Gao X, Mao J, Zhu Y, Wu P, et al. Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury. J Control Release. 2020;317:259\u201372.","journal-title":"J Control Release"},{"issue":"02","key":"5503_CR31","first-page":"265","volume":"51","author":"Y Li","year":"2020","unstructured":"Li Y, Jiang YL, Lu D, Dong CS, Pu YW, Yang P, Sun L. Ginsenoside Rb1 improving autophagic flux against myocardial ischemia reperfusion injury in isolated-heart of rat. Acta Anat Sinica. 2020;51(02):265\u201372.","journal-title":"Acta Anat Sinica"},{"issue":"1","key":"5503_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1139\/cjpp-2014-0164","volume":"94","author":"G Li","year":"2016","unstructured":"Li G, Qian W, Zhao C. Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the Inhibition of p38\u03b1 MAPK. Can J Physiol Pharmacol. 2016;94(1):97\u2013103.","journal-title":"Can J Physiol Pharmacol"},{"key":"5503_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fphys.2018.00078","volume":"9","author":"L Li","year":"2018","unstructured":"Li L, Pan CS, Yan L, Cui YC, Liu YY, Mu HN, He K, Hu BH, Chang X, Sun K, et al. Ginsenoside Rg1 ameliorates rat myocardial Ischemia-Reperfusion injury by modulating energy metabolism pathways. Front Physiol. 2018;9:78.","journal-title":"Front Physiol"},{"key":"5503_CR34","doi-asserted-by":"publisher","first-page":"824657","DOI":"10.3389\/fcvm.2022.824657","volume":"9","author":"Y Li","year":"2022","unstructured":"Li Y, Hao H, Yu H, Yu L, Ma H, Zhang H. Ginsenoside Rg2 ameliorates myocardial Ischemia\/Reperfusion injury by regulating TAK1 to inhibit necroptosis. Front Cardiovasc Med. 2022;9:824657.","journal-title":"Front Cardiovasc Med"},{"issue":"07","key":"5503_CR35","first-page":"1080","volume":"21","author":"CE Liu","year":"2012","unstructured":"Liu CE, Wu SX, Ye G. Mechanismof GinsenosideRb1 against myocardial apoptosisduring Ischemia-reperfusion injury in diabetic rats. J Emerg Traditional Chin Med. 2012;21(07):1080\u20131.","journal-title":"J Emerg Traditional Chin Med"},{"issue":"6","key":"5503_CR36","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3892\/etm.2014.2007","volume":"8","author":"X Liu","year":"2014","unstructured":"Liu X, Jiang Y, Yu X, Fu W, Zhang H, Sui D. Ginsenoside-Rb3 protects the myocardium from ischemia-reperfusion injury via the Inhibition of apoptosis in rats. Exp Ther Med. 2014;8(6):1751\u20136.","journal-title":"Exp Ther Med"},{"issue":"2","key":"5503_CR37","first-page":"519","volume":"45","author":"X Liu","year":"2020","unstructured":"Liu X, Jiang Y, Fu W, Yu X, Sui D. Combination of the ginsenosides Rb3 and Rb2 exerts protective effects against myocardial ischemia reperfusion injury in rats. Int J Mol Med. 2020;45(2):519\u201331.","journal-title":"Int J Mol Med"},{"key":"5503_CR38","unstructured":"Qu SC, Sui C, Yu XF, Wang XH, He XX, Xu HL. Protective effects of Ginsenoside-Rb on experimental myocardial ischemia-reperfusion injury in rats. J Jilin Univ (Medicine Edition). 2007;33(05):849\u201352."},{"issue":"08","key":"5503_CR39","first-page":"18","volume":"13","author":"XW Rao","year":"2013","unstructured":"Rao XW, Ye ZB. The protection and mechanism of ginsenosid Rg2 peprocessing Agaist apoptosis in ischemia and reperfusion injury of myocardium of rat. Mod Hosp. 2013;13(08):18\u201320.","journal-title":"Mod Hosp"},{"issue":"17","key":"5503_CR40","first-page":"2094","volume":"34","author":"K Shao","year":"2018","unstructured":"Shao K, Yang CM, Zhou Q, Zhou J, Wang L, Wang X, Dang S. Protective effect and its mechanism of ginsenoside Rh2 on myocardial ischemia-reperfusion injury in high fat diet rats. Chin J Clin Pharmacol. 2018;34(17):2094\u20136.","journal-title":"Chin J Clin Pharmacol"},{"issue":"9","key":"5503_CR41","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3109\/13880209.2011.554845","volume":"49","author":"Y Shi","year":"2011","unstructured":"Shi Y, Han B, Yu X, Qu S, Sui D. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharm Biol. 2011;49(9):900\u20136.","journal-title":"Pharm Biol"},{"issue":"6","key":"5503_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10557-008-6129-4","volume":"22","author":"Z Wang","year":"2008","unstructured":"Wang Z, Li M, Wu WK, Tan HM, Geng DF. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther. 2008;22(6):443\u201352.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"5503_CR43","doi-asserted-by":"publisher","first-page":"e70956","DOI":"10.1371\/journal.pone.0070956","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li X, Wang X, Lau W, Wang Y, Xing Y, Zhang X, Ma X, Gao F. Ginsenoside Rd attenuates myocardial ischemia\/reperfusion injury via Akt\/GSK-3\u03b2 signaling and Inhibition of the mitochondria-dependent apoptotic pathway. PLoS ONE. 2013;8(8):e70956.","journal-title":"PLoS ONE"},{"issue":"6","key":"5503_CR44","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.3892\/mmr.2015.3336","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Hu Z, Sun B, Xu J, Jiang J, Luo M. Ginsenoside Rg3 attenuates myocardial ischemia\/reperfusion injury via Akt\/endothelial nitric oxide synthase signaling and the B\u2013cell lymphoma\/B\u2013cell lymphoma\u2013associated X protein pathway. Mol Med Rep. 2015;11(6):4518\u201324.","journal-title":"Mol Med Rep"},{"issue":"A1","key":"5503_CR45","first-page":"89","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhang YY. Protective effect of ginsenoside Rb1 on ischemia\/reperfusion-injured myocardium through P38MAPK signaling pathway and mechanism study. World Latest Med Inform. 2016;16(A1):89\u201390.","journal-title":"World Latest Med Inform"},{"issue":"11","key":"5503_CR46","first-page":"2783","volume":"35","author":"JD Wang","year":"2017","unstructured":"Wang JD, Cui Y, Wang JG, Li H, Dai JC, Ma HY, Li SD. Ginseng saponin Rh3 pretreatment to protect myocardial Ischemia-Reperfusion injury in rats. Chin Archives Traditional Chin Med. 2017;35(11):2783\u20136.","journal-title":"Chin Archives Traditional Chin Med"},{"issue":"7","key":"5503_CR47","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1007\/s11033-010-0558-4","volume":"38","author":"Y Wu","year":"2011","unstructured":"Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM. Protective effect of ginsenoside Rb1 against myocardial ischemia\/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep. 2011;38(7):4327\u201335.","journal-title":"Mol Biol Rep"},{"issue":"49","key":"5503_CR48","first-page":"7320","volume":"20","author":"HZ Wu","year":"2016","unstructured":"Wu HZ, Jia QZ. Protective effects of ginsenoside Rb3 on a rat model of ischemia\/reperfusion injury. Chin J Tissue Eng Res. 2016;20(49):7320\u20136.","journal-title":"Chin J Tissue Eng Res"},{"key":"5503_CR49","first-page":"767930","volume":"2011","author":"R Xia","year":"2011","unstructured":"Xia R, Zhao B, Wu Y, Hou JB, Zhang L, Xu JJ, Xia ZY. Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia\/reperfusion injury in diabetic rats. J Biomed Biotechnol. 2011;2011:767930.","journal-title":"J Biomed Biotechnol"},{"issue":"11","key":"5503_CR50","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1111\/1750-3841.15505","volume":"85","author":"Y Xue","year":"2020","unstructured":"Xue Y, Fu W, Liu Y, Yu P, Sun M, Li X, Yu X, Sui D. Ginsenoside Rb2 alleviates myocardial ischemia\/reperfusion injury in rats through SIRT1 activation. J Food Sci. 2020;85(11):4039\u201349.","journal-title":"J Food Sci"},{"issue":"3","key":"5503_CR51","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1021\/acs.jafc.2c06926","volume":"71","author":"Y Xue","year":"2023","unstructured":"Xue Y, Fu W, Yu P, Li Y, Yu X, Xu H, Sui D. Ginsenoside Rc alleviates myocardial Ischemia-Reperfusion injury by reducing mitochondrial oxidative stress and apoptosis: role of SIRT1 activation. J Agric Food Chem. 2023;71(3):1547\u201361.","journal-title":"J Agric Food Chem"},{"issue":"07","key":"5503_CR52","first-page":"1575","volume":"37","author":"Y Xu","year":"2016","unstructured":"Xu Y, Chen XH, Ma HW. Effect of ginsenosides Rg2 on SOD and MDA of myocardial ischemia reperfusion in rats. Jilin Med J. 2016;37(07):1575\u20136.","journal-title":"Jilin Med J"},{"key":"5503_CR53","doi-asserted-by":"publisher","first-page":"154681","DOI":"10.1016\/j.phymed.2023.154681","volume":"113","author":"J Ye","year":"2023","unstructured":"Ye J, Lyu TJ, Li LY, Liu Y, Zhang H, Wang X, Xi X, Liu ZJ, Gao JQ. Ginsenoside re attenuates myocardial ischemia\/reperfusion induced ferroptosis via miR-144-3p\/SLC7A11. Phytomedicine. 2023;113:154681.","journal-title":"Phytomedicine"},{"issue":"8","key":"5503_CR54","first-page":"14497","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Li J, Li Z. Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2\/HO-1 signaling pathway. Int J Clin Exp Med. 2015;8(8):14497\u2013504.","journal-title":"Int J Clin Exp Med"},{"issue":"03","key":"5503_CR55","first-page":"446","volume":"12","author":"L Zhang","year":"2010","unstructured":"Zhang L, Xia ZY. Protective effect of ginsenoside Rb1 Pre-conditioninlg on myocardium against Ischemia-reperfusion Inj Ury Ln diabetic rats. Chin J Med Guide. 2010;12(03):446\u20139.","journal-title":"Chin J Med Guide"},{"key":"5503_CR56","doi-asserted-by":"publisher","first-page":"6967853","DOI":"10.1155\/2016\/6967853","volume":"2016","author":"LP Zhang","year":"2016","unstructured":"Zhang LP, Jiang YC, Yu XF, Xu HL, Li M, Zhao XZ, Sui DY. Ginsenoside Rg3 improves cardiac function after myocardial Ischemia\/Reperfusion via attenuating apoptosis and inflammation. Evid Based Complement Alternat Med. 2016;2016:6967853.","journal-title":"Evid Based Complement Alternat Med"},{"key":"5503_CR57","doi-asserted-by":"publisher","first-page":"108299","DOI":"10.1016\/j.intimp.2021.108299","volume":"101Pt B","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhao F, Yuan Z, Wang C, Chen K, Xiao W. Inhibition of miR-218-5p reduces myocardial ischemia-reperfusion injury in a Sprague-Dawley rat model by reducing oxidative stress and inflammation through MEF2C\/NF-\u03baB pathway. Int Immunopharmacol. 2021;101Pt B:108299.","journal-title":"Int Immunopharmacol"},{"issue":"16","key":"5503_CR58","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/ars.2019.7734","volume":"31","author":"T Sun","year":"2019","unstructured":"Sun T, Ding W, Xu T, Ao X, Yu T, Li M, Liu Y, Zhang X, Hou L, Wang J. Parkin regulates programmed necrosis and myocardial Ischemia\/Reperfusion injury by targeting Cyclophilin-D. Antioxid Redox Signal. 2019;31(16):1177\u201393.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"5503_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cjtee.2022.06.008","volume":"26","author":"T Zhu","year":"2023","unstructured":"Zhu T, Wan Q. Pharmacological properties and mechanisms of notoginsenoside R1 in ischemia-reperfusion injury. Chin J Traumatol. 2023;26(1):20\u20136.","journal-title":"Chin J Traumatol"},{"key":"5503_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mito.2015.11.003","volume":"26","author":"G Dong","year":"2016","unstructured":"Dong G, Chen T, Ren X, Zhang Z, Huang W, Liu L, Luo P, Zhou H. Rg1 prevents myocardial hypoxia\/reoxygenation injury by regulating mitochondrial dynamics imbalance via modulation of glutamate dehydrogenase and Mitofusin 2. Mitochondrion. 2016;26:7\u201318.","journal-title":"Mitochondrion"},{"key":"5503_CR61","doi-asserted-by":"publisher","first-page":"690190","DOI":"10.1155\/2013\/690190","volume":"2013","author":"J Sun","year":"2013","unstructured":"Sun J, Sun G, Meng X, Wang H, Wang M, Qin M, Ma B, Luo Y, Yu Y, Chen R, et al. Ginsenoside RK3 prevents Hypoxia-Reoxygenation induced apoptosis in H9c2 cardiomyocytes via AKT and MAPK pathway. Evid Based Complement Alternat Med. 2013;2013:690190.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"5503_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1538\/expanim.16-0121","volume":"66","author":"X Zheng","year":"2017","unstructured":"Zheng X, Wang S, Zou X, Jing Y, Yang R, Li S, Wang F. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp Anim. 2017;66(3):217\u201328.","journal-title":"Exp Anim"},{"issue":"8","key":"5503_CR63","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1142\/S0192415X21500907","volume":"49","author":"GW Qin","year":"2021","unstructured":"Qin GW, Lu P, Peng L, Jiang W. Ginsenoside Rb1 inhibits cardiomyocyte autophagy via PI3K\/Akt\/mTOR signaling pathway and reduces myocardial Ischemia\/Reperfusion injury. Am J Chin Med. 2021;49(8):1913\u201327.","journal-title":"Am J Chin Med"},{"issue":"6","key":"5503_CR64","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/aps.2010.52","volume":"31","author":"HL Kong","year":"2010","unstructured":"Kong HL, Li ZQ, Zhao YJ, Zhao SM, Zhu L, Li T, Fu Y, Li HJ. Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening. Acta Pharmacol Sin. 2010;31(6):687\u201395.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"5503_CR65","doi-asserted-by":"publisher","first-page":"12746","DOI":"10.3390\/molecules171112746","volume":"17","author":"JR Wang","year":"2012","unstructured":"Wang JR, Zhou H, Yi XQ, Jiang ZH, Liu L. Total ginsenosides of radix ginseng modulates Tricarboxylic acid cycle protein expression to enhance cardiac energy metabolism in ischemic rat heart tissues. Molecules. 2012;17(11):12746\u201357.","journal-title":"Molecules"},{"key":"5503_CR66","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12906-016-1112-2","volume":"16","author":"D Li","year":"2016","unstructured":"Li D, Wang J, Hou J, Fu J, Chang D, Bensoussan A, Liu J. Ginsenoside Rg1 protects starving H9c2 cells by dissociation of Bcl-2-Beclin1 complex. BMC Complement Altern Med. 2016;16:146.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"5503_CR67","doi-asserted-by":"publisher","first-page":"H851","DOI":"10.1152\/ajpheart.01242.2007","volume":"295","author":"YG Wang","year":"2008","unstructured":"Wang YG, Zima AV, Ji X, Pabbidi R, Blatter LA, Lipsius SL. Ginsenoside re suppresses electromechanical alternans in Cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol. 2008;295(2):H851\u2013859.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5503_CR68","doi-asserted-by":"publisher","first-page":"118506","DOI":"10.1016\/j.jep.2024.118506","volume":"334","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Li M, Zhang Z, Song Z, Xu J, Zhang M, Gong M. Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases. J Ethnopharmacol. 2024;334:118506.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"5503_CR69","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1745-7254.2008.00869.x","volume":"29","author":"KT Choi","year":"2008","unstructured":"Choi KT. Botanical characteristics, Pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin. 2008;29(9):1109\u201318.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"5503_CR70","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1211\/jpp.60.11.0015","volume":"60","author":"WM Lee","year":"2008","unstructured":"Lee WM, Kim SD, Park MH, Cho JY, Park HJ, Seo GS, Rhee MH. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. J Pharm Pharmacol. 2008;60(11):1531\u20136.","journal-title":"J Pharm Pharmacol"},{"key":"5503_CR71","doi-asserted-by":"publisher","first-page":"847748","DOI":"10.3389\/fphar.2022.847748","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Shou X, Fan Z, Cui J, Xue D, Wu Y. A systematic review and Meta-Analysis of phytoestrogen protects against myocardial Ischemia\/Reperfusion injury: Pre-Clinical evidence from small animal studies. Front Pharmacol. 2022;13:847748.","journal-title":"Front Pharmacol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05503-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:03:49Z","timestamp":1770728629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05503-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5503"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05503-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}